1
/
of
1
Naphcon-A (Pheniramine Maleate + Naphazoline Hydrochloride)
Naphcon-A (Pheniramine Maleate + Naphazoline Hydrochloride)
Regular price
₱710.00 PHP
Regular price
Sale price
₱710.00 PHP
Taxes included.
Quantity
Couldn't load pickup availability
Naphcon-A is a dual-action ophthalmic decongestant and antihistamine solution combining pheniramine maleate and naphazoline hydrochloride to address allergic eye symptoms and ocular congestion. This prescription-strength formulation targets itching, redness, watering, and swelling caused by allergies, environmental irritants, or seasonal allergen exposure.
Pheniramine maleate, a first-generation antihistamine, blocks histamine H1 receptors on ocular mast cells and conjunctival tissues, rapidly reducing itching and allergic inflammation. Naphazoline hydrochloride functions as an alpha-adrenergic decongestant, constricting blood vessels in the conjunctiva to diminish redness, puffiness, and hyperemia associated with allergic reactions.
The combination formulation provides synergistic relief—antihistamine action addresses the root allergic response while decongestant activity reduces visible inflammation and discomfort. This dual mechanism makes Naphcon-A particularly effective for patients experiencing moderate to severe allergic conjunctivitis, seasonal allergies affecting the eyes, or post-exposure irritation from pollen, dust, pet dander, or other allergens.
Naphcon-A delivers rapid onset within minutes, with peak efficacy sustained for several hours per dose. The sterile ophthalmic solution format ensures precise instillation and consistent potency across each application. Users typically experience significant relief from ocular pruritis, lacrimation, and conjunctival injection.
Suitable for adults and children under clinical supervision, Naphcon-A is indicated for temporary symptomatic management of allergic eye conditions. Regular use during high-allergen periods or as directed by a healthcare provider maximizes therapeutic benefit and maintains ocular comfort throughout the day.
Naphcon-A represents a clinically trusted option for allergy-related eye symptoms, offering efficient dual-action relief for patients requiring robust management of allergic ocular inflammation.
Pheniramine maleate, a first-generation antihistamine, blocks histamine H1 receptors on ocular mast cells and conjunctival tissues, rapidly reducing itching and allergic inflammation. Naphazoline hydrochloride functions as an alpha-adrenergic decongestant, constricting blood vessels in the conjunctiva to diminish redness, puffiness, and hyperemia associated with allergic reactions.
The combination formulation provides synergistic relief—antihistamine action addresses the root allergic response while decongestant activity reduces visible inflammation and discomfort. This dual mechanism makes Naphcon-A particularly effective for patients experiencing moderate to severe allergic conjunctivitis, seasonal allergies affecting the eyes, or post-exposure irritation from pollen, dust, pet dander, or other allergens.
Naphcon-A delivers rapid onset within minutes, with peak efficacy sustained for several hours per dose. The sterile ophthalmic solution format ensures precise instillation and consistent potency across each application. Users typically experience significant relief from ocular pruritis, lacrimation, and conjunctival injection.
Suitable for adults and children under clinical supervision, Naphcon-A is indicated for temporary symptomatic management of allergic eye conditions. Regular use during high-allergen periods or as directed by a healthcare provider maximizes therapeutic benefit and maintains ocular comfort throughout the day.
Naphcon-A represents a clinically trusted option for allergy-related eye symptoms, offering efficient dual-action relief for patients requiring robust management of allergic ocular inflammation.
Share
